Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HON vs EMR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HON
Honeywell International Inc.

Conglomerates

IndustrialsNASDAQ • US
Market Cap$137.39B
5Y Perf.+48.7%
EMR
Emerson Electric Co.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$83.18B
5Y Perf.+142.4%

HON vs EMR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HON logoHON
EMR logoEMR
IndustryConglomeratesIndustrial - Machinery
Market Cap$137.39B$83.18B
Revenue (TTM)$36.76B$18.32B
Net Income (TTM)$4.10B$2.44B
Gross Margin36.9%39.4%
Operating Margin14.9%19.4%
Forward P/E20.6x22.8x
Total Debt$34.58B$13.76B
Cash & Equiv.$12.49B$1.54B

HON vs EMRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HON
EMR
StockMay 20May 26Return
Honeywell Internati… (HON)100148.7+48.7%
Emerson Electric Co. (EMR)100242.4+142.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: HON vs EMR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HON leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Emerson Electric Co. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
HON
Honeywell International Inc.
The Income Pick

HON carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 15 yrs, beta 0.74, yield 2.1%
  • Rev growth 7.8%, EPS growth -15.5%, 3Y rev CAGR 1.8%
  • Lower volatility, beta 0.74, current ratio 1.32x
Best for: income & stability and growth exposure
EMR
Emerson Electric Co.
The Long-Run Compounder

EMR is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 215.5% 10Y total return vs HON's 134.6%
  • PEG 5.04 vs HON's 11.22
  • 13.3% margin vs HON's 11.2%
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthHON logoHON7.8% revenue growth vs EMR's 3.0%
ValueHON logoHONLower P/E (20.6x vs 22.8x)
Quality / MarginsEMR logoEMR13.3% margin vs HON's 11.2%
Stability / SafetyHON logoHONBeta 0.74 vs EMR's 1.52
DividendsHON logoHON2.1% yield, 15-year raise streak, vs EMR's 1.4%
Momentum (1Y)EMR logoEMR+39.9% vs HON's +5.5%
Efficiency (ROA)EMR logoEMR5.8% ROA vs HON's 5.3%, ROIC 8.2% vs 12.6%

HON vs EMR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HONHoneywell International Inc.
FY 2025
Aerospace
46.8%$17.5B
Safety And Productivity Solutions
25.1%$9.4B
Home And Building Technologies
19.7%$7.4B
Energy and Sustainability Solutions
8.4%$3.1B
EMREmerson Electric Co.
FY 2025
Intelligent Devices
68.5%$12.4B
Software and Control
31.5%$5.7B

HON vs EMR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEMRLAGGINGHON

Income & Cash Flow (Last 12 Months)

EMR leads this category, winning 6 of 6 comparable metrics.

HON is the larger business by revenue, generating $36.8B annually — 2.0x EMR's $18.3B. Profitability is closely matched — net margins range from 13.3% (EMR) to 11.2% (HON). On growth, EMR holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHON logoHONHoneywell Interna…EMR logoEMREmerson Electric …
RevenueTrailing 12 months$36.8B$18.3B
EBITDAEarnings before interest/tax$6.5B$4.7B
Net IncomeAfter-tax profit$4.1B$2.4B
Free Cash FlowCash after capex$4.2B$3.1B
Gross MarginGross profit ÷ Revenue+36.9%+39.4%
Operating MarginEBIT ÷ Revenue+14.9%+19.4%
Net MarginNet income ÷ Revenue+11.2%+13.3%
FCF MarginFCF ÷ Revenue+11.4%+17.0%
Rev. Growth (YoY)Latest quarter vs prior year-6.9%+2.9%
EPS Growth (YoY)Latest quarter vs prior year-41.9%+28.2%
EMR leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

HON leads this category, winning 4 of 7 comparable metrics.

At 29.5x trailing earnings, HON trades at a 20% valuation discount to EMR's 36.6x P/E. Adjusting for growth (PEG ratio), EMR offers better value at 8.11x vs HON's 16.04x — a lower PEG means you pay less per unit of expected earnings growth.

MetricHON logoHONHoneywell Interna…EMR logoEMREmerson Electric …
Market CapShares × price$137.4B$83.2B
Enterprise ValueMkt cap + debt − cash$159.5B$95.4B
Trailing P/EPrice ÷ TTM EPS29.46x36.61x
Forward P/EPrice ÷ next-FY EPS est.20.60x22.77x
PEG RatioP/E ÷ EPS growth rate16.04x8.11x
EV / EBITDAEnterprise value multiple20.05x18.89x
Price / SalesMarket cap ÷ Revenue3.67x4.62x
Price / BookPrice ÷ Book value/share9.03x4.13x
Price / FCFMarket cap ÷ FCF25.48x31.19x
HON leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

EMR leads this category, winning 6 of 9 comparable metrics.

HON delivers a 23.1% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $12 for EMR. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs HON's 6/9, reflecting strong financial health.

MetricHON logoHONHoneywell Interna…EMR logoEMREmerson Electric …
ROE (TTM)Return on equity+23.1%+12.1%
ROA (TTM)Return on assets+5.3%+5.8%
ROICReturn on invested capital+12.6%+8.2%
ROCEReturn on capital employed+12.6%+10.0%
Piotroski ScoreFundamental quality 0–967
Debt / EquityFinancial leverage2.24x0.68x
Net DebtTotal debt minus cash$22.1B$12.2B
Cash & Equiv.Liquid assets$12.5B$1.5B
Total DebtShort + long-term debt$34.6B$13.8B
Interest CoverageEBIT ÷ Interest expense3.92x6.61x
EMR leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

EMR leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in EMR five years ago would be worth $16,900 today (with dividends reinvested), compared to $10,364 for HON. Over the past 12 months, EMR leads with a +39.9% total return vs HON's +5.5%. The 3-year compound annual growth rate (CAGR) favors EMR at 22.6% vs HON's 5.2% — a key indicator of consistent wealth creation.

MetricHON logoHONHoneywell Interna…EMR logoEMREmerson Electric …
YTD ReturnYear-to-date+11.3%+9.3%
1-Year ReturnPast 12 months+5.5%+39.9%
3-Year ReturnCumulative with dividends+16.6%+84.1%
5-Year ReturnCumulative with dividends+3.6%+69.0%
10-Year ReturnCumulative with dividends+134.6%+215.5%
CAGR (3Y)Annualised 3-year return+5.2%+22.6%
EMR leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.

HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricHON logoHONHoneywell Interna…EMR logoEMREmerson Electric …
Beta (5Y)Sensitivity to S&P 5000.74x1.52x
52-Week HighHighest price in past year$248.18$165.15
52-Week LowLowest price in past year$186.76$106.53
% of 52W HighCurrent price vs 52-week peak+87.4%+89.6%
RSI (14)Momentum oscillator 0–10032.348.4
Avg Volume (50D)Average daily shares traded3.7M2.8M
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.

Wall Street rates HON as "Buy" and EMR as "Buy". Consensus price targets imply 12.5% upside for HON (target: $244) vs 9.5% for EMR (target: $162). For income investors, HON offers the higher dividend yield at 2.14% vs EMR's 1.42%.

MetricHON logoHONHoneywell Interna…EMR logoEMREmerson Electric …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$243.83$161.92
# AnalystsCovering analysts2841
Dividend YieldAnnual dividend ÷ price+2.1%+1.4%
Dividend StreakConsecutive years of raises1537
Dividend / ShareAnnual DPS$4.63$2.10
Buyback YieldShare repurchases ÷ mkt cap+2.8%+1.5%
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Key Takeaway

EMR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HON leads in 1 (Valuation Metrics). 2 tied.

Best OverallEmerson Electric Co. (EMR)Leads 3 of 6 categories
Loading custom metrics...

HON vs EMR: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HON or EMR a better buy right now?

For growth investors, Honeywell International Inc.

(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Honeywell International Inc. (HON) offers the better valuation at 29. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Honeywell International Inc. (HON) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HON or EMR?

On trailing P/E, Honeywell International Inc.

(HON) is the cheapest at 29. 5x versus Emerson Electric Co. at 36. 6x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Emerson Electric Co. wins at 5. 04x versus Honeywell International Inc. 's 11. 22x.

03

Which is the better long-term investment — HON or EMR?

Over the past 5 years, Emerson Electric Co.

(EMR) delivered a total return of +69. 0%, compared to +3. 6% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: EMR returned +215. 5% versus HON's +134. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HON or EMR?

By beta (market sensitivity over 5 years), Honeywell International Inc.

(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — HON or EMR?

By revenue growth (latest reported year), Honeywell International Inc.

(HON) is pulling ahead at 7. 8% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HON or EMR?

Emerson Electric Co.

(EMR) is the more profitable company, earning 12. 7% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 17. 5% for HON. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HON or EMR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Emerson Electric Co. (EMR) is the more undervalued stock at a PEG of 5. 04x versus Honeywell International Inc. 's 11. 22x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 6x forward P/E versus 22. 8x for Emerson Electric Co. — 2. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HON: 12. 5% to $243. 83.

08

Which pays a better dividend — HON or EMR?

All stocks in this comparison pay dividends.

Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 1. 4% for Emerson Electric Co. (EMR).

09

Is HON or EMR better for a retirement portfolio?

For long-horizon retirement investors, Honeywell International Inc.

(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +134. 6% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +134. 6%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HON and EMR?

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HON

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 6%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

EMR

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HON and EMR on the metrics below

Revenue Growth>
%
(HON: -6.9% · EMR: 2.9%)
Net Margin>
%
(HON: 11.2% · EMR: 13.3%)
P/E Ratio<
x
(HON: 29.5x · EMR: 36.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.